反応式
[Cl:1][C:2]1[CH:3]=[C:4]([CH:8]2[C:13]([C:14]([OH:16])=O)=[C:12]([CH3:17])[NH:11][C:10](=[O:18])[NH:9]2)[CH:5]=[CH:6][CH:7]=1.[NH2:19][CH2:20][CH2:21][CH2:22][N:23]1[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1.CCN=C=NCCCN(C)C.Cl>CN(C=O)C>[N:23]1([CH2:22][CH2:21][CH2:20][NH:19][C:14]([C:13]2[CH:8]([C:4]3[CH:5]=[CH:6][CH:7]=[C:2]([Cl:1])[CH:3]=3)[NH:9][C:10](=[O:18])[NH:11][C:12]=2[CH3:17])=[O:16])[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
240 mg (0.900 mmol) of 4-(3-chlorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid and 156 mg (1.08 mmol) of N-(3-aminopropyl)morpholine were dissolved in 10 ml of DMF. 259 mg (1.35 mmol) of WSC hydrochloride was added to the obtained solution under cooling with ice, and they were stirred at room temperature overnight. After the concentration under reduced pressure, the reaction mixture was diluted with ethyl acetate and then washed with saturated aqueous sodium hydrogencarbonate solution and saturated aqueous sodium chloride solution. The organic layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure. The residue was purified by the silica gel chromatography (dichloromethane/methanol=50/1 to 10/1) to obtain the title compound.
後処理
- temperatureunder cooling with ice, and they
- concentrationAfter the concentration under reduced pressure
- additionthe reaction mixture was diluted with ethyl acetate
- washwashed with saturated aqueous sodium hydrogencarbonate solution and saturated aqueous sodium chloride solution
- dry with materialThe organic layer was dried over anhydrous magnesium sulfate
- concentrationconcentrated under reduced pressure
- customThe residue was purified by the silica gel chromatography (dichloromethane/methanol=50/1 to 10/1)
出典と根拠
- ORDレコード
- ord-e10e483550ec47179b5dd841c25d4ddd
- 出典データセット
- uspto-grants-2005_02
- 特許番号
- US06855716B2
関連ノート
読み込み中…